Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power–Injectable Totally Implanted Venous Access Devices among Cancer Patients

Burbridge, Brent; Plewes, Chris; Stoneham, Grant; Szkup, Peter; Otani, Rob; Babyn, Paul; Bryce, Rhonda

doi:10.1016/j.jvir.2017.11.028

Cited by 6 publications

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PORT which allow the administration of high flows and contrast media should be preferred. 49,50 3) It is recommended that the ratio of catheter caliber to vein diameter should not exceed 1/3. (A II)…”

Section: Indications For Insertion and Selection Of The Cvadmentioning

confidence: 99%

Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease

et al. 2020

View full text Add to dashboard Cite

Introduction: Central venous accesses devices (CVADs) have a fundamental importance for diagnostic and therapeutic purposes in pediatric onco-hematological patients. The treatment of pediatric onco-hematological diseases is complex and requires the use of integrated multimodal therapies. Long-lasting and safe central venous access is therefore a cornerstone for any successful treatment. Methods: The aim of this work is to define pediatric guidelines about the management of CVADs in onco-hematology. A panel of experts belonging to the working groups on Infections and Supportive Therapy, Surgery and Nursing of the Italian Pediatric Hematology Oncology Association (AIEOP) revised the scientific literature systematically, scored the level of evidence and prepared these guidelines. The content of the following guidelines was approved by the Scientific Board of AIEOP. Results and Conclusions: Important innovations have been developed recently in the field of CVADs, leading to new insertion methods, new materials and new strategy in the overall management of the device, especially in the adult population. These guidelines recommend how to apply these innovations in the pediatric population, and are directed to all physicians, nurses and health personnel active in the daily management of CVADs. Their aim is to update the knowledge on CVAD and improve the standard of care in pediatric patients with malignancies.

show abstract

Section: Indications For Insertion and Selection Of The Cvadmentioning

confidence: 99%

Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The power injectable lock had structural strength in the extension line of the non-coring needle. From the literature reviews, preliminary results showed the power port to have a similar complication rate as conventional ports [32,33]. As the power port could serve as entry access for the chemotherapeutic agent and contrast medium, the frequency of venipuncture was much decreased, and the patients' satisfaction were higher than conventional port [34].…”

Section: Discussionmentioning

confidence: 99%

Difference in Computed Tomography Image Quality between Central Vein and Peripheral Vein Enhancement in Treatment Naive Esophageal Cancer Patients

Chang

Chen

et al. 2021

Cancers

View full text Add to dashboard Cite

The differences in chest computed tomography (CT) image quality may affect the tumor stage. The aim of this study was to compare the image quality and accuracy of chest CT via central vein and peripheral vein enhancement. Fifty consecutive patients were enrolled from a tertiary medical center in Taiwan from May 2016 to March 2019. All the patients received a chest CT via central vein enhancement prior to neoadjuvant concurrent chemoradiation in order to compare the chest CT that was obtained via the peripheral vein. In addition, blind independent central reviews of chest CT via central vein and peripheral vein enhancement were conducted. For T and N stage, chest CT via central vein enhancement had a greater consistency with endoscopic ultrasonography and positron-emission tomography-computed tomography findings (kappa coefficients 0.4471 and 0.5564, respectively). In addition, chest CT via central vein enhancement also showed excellent agreement in the blind independent central review (kappa coefficient 0.9157). The changes in the T and N stage resulted in stage migration in 16 patients. Chest CT via central vein enhancement eliminated peripheral vein regurgitation and also provided more precise clinical staging. This study is registered under the registered NCT number 02887261.

show abstract

“…Additionally, the detection of venous thrombosis was based on clinical signs and symptoms; this may not be a reliable method of thrombosis detection because there is a tendency for asymptomatic venous thrombosis to develop in this patient group [ 16 ]. Given that power injectable venous devices are usually associated with a larger catheter diameter, which has been proven to increase the risk of venous thrombosis, the role that power injection may play in the treatment and follow-up of patients should be balanced against the potential risk for venous thrombosis [ 5 ].…”

Section: Discussionmentioning

confidence: 99%

“…The current PICC, used for all subjects, was power-injectable. Technical details for these device implantation procedures have been previously described and were followed for this project [ 5 , 6 ]. As per institutional guidelines, PICCs were flushed once weekly, whereas ports were flushed every 4 weeks when not in use.…”

Section: Methodsmentioning

confidence: 99%

Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC)

et al. 2021

Self Cite

View full text Add to dashboard Cite

Introduction: Venous access is a crucial element in chemotherapy delivery. It remains unclear whether cancer patients prefer a port to a peripherally inserted central catheter (PICC). Our study aimed to assess cancer patients’ satisfaction with their venous access device and to compare the quality of life (QoL) of subjects with a PICC to those with a port. Methods: In this prospective cohort study, EORTC QLQ-C30, and a locally developed quality of life survey (QLAVD), designed to assess satisfaction with venous access devices, were administered to breast or colorectal cancer patients over a one-year period following the device insertion. Mixed effects models were used to assess changes on mean scores at different time points. Results: A total of 101 patients were recruited over a three-year period, (PICC group, n = 50; port group, n = 51). Survey response rates for months one and three were 72% and 48%, respectively. Overall, no significant differences were noted between the two groups in relation to EORTC QOL. At three months, the mean pain scores were 3.5 ± 2.3 for the port and 1.3 ± 0.75 for PICC (<0.001). The mean score for a negative effect of the venous access device on psychosocial well-being was 6.0 ± 4.1 for PICC and 3.0 ± 2.7 for the port (p = 0.005). Complications related to PICCs occurred in 38% patients versus 41% with a port (p > 0.24). Conclusions: Although subjects with a port experienced more pain during the device insertion or access for chemotherapy, it had a smaller negative impact on psychosocial scores than the PICC. No significant differences in complications rates were observed between the two devices.

show abstract

Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power–Injectable Totally Implanted Venous Access Devices among Cancer Patients

Cited by 6 publications

References 17 publications

Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease

Guidelines of the Italian Association of Pediatric Hematology and Oncology for the management of the central venous access devices in pediatric patients with onco-hematological disease

Difference in Computed Tomography Image Quality between Central Vein and Peripheral Vein Enhancement in Treatment Naive Esophageal Cancer Patients

Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC)

Contact Info

Product

Resources

About